嘉应制药 (002198)
GUANGDONG JIAYING PHARMACEUTICAL CO., LTD.
K-Line Chart
No K-line data available
Company NameGuangdong Jiaying Pharmaceutical Co., Ltd.
Listing Date2007-12-18
Issue Price5.99RMB
Registered Capital50750.984810k RMB
Legal RepresentativeLi Neng
Registered AddressZone B, Dongsheng Industrial Park, Meizhou City, Guangdong Province
IndustryTraditional Chinese Medicine II
Main BusinessResearch, development, production, and sales of Chinese patent medicines, with throat and cold Chinese patent medicines as the leading products.
Company ProfileGuangdong Jiaying Pharmaceutical Co., Ltd. is an integrated Chinese patent medicine enterprise engaged in research, development, production, and sales. The company was established in 2003 through the restructuring of Guangdong Meizhou Pharmaceutical Factory and was listed on the Shenzhen Stock Exchange in December 2007. Stock abbreviation: Jiaying Pharmaceutical, Stock code: 002198. Currently, the company has two pharmaceutical R&D, production, and sales bases in Changsha, Hunan Province, and Meizhou, Guangdong Province, with total assets exceeding 1 billion yuan and a market capitalization of over 6 billion yuan. The company possesses 5 dosage forms and 70 drug approval numbers, with products covering throat, cold, orthopedic, rheumatism, gynecological, heat-clearing, tonic, and gastrointestinal categories. Leading products such as Shuangliao Houfeng San, Zhongganling Tablets, Jiegu Qili Tablets (Capsules), Shufeng Huoluo Tablets, and Tiaojing Huoxue Tablets are all national protected traditional Chinese medicine varieties and patented varieties. Shuangliao Houfeng San was developed from a Qing Dynasty folk secret recipe, with a history of nearly three hundred years. Its production process is unique, its efficacy is definite, and its application is widespread. It enjoys high recognition and reputation in throat medicine and is well-received by consumers.
Stock Details
1. Key Indicators
- Total Shares(W): 50750.98
- Circulating A-Shares(W): 50748.07
- Earnings Per Share(RMB): 0.0429
- Net Assets Per Share(RMB): 1.3970
- Operating Revenue(W RMB): 29343.63
- Total Profit(W RMB): 2574.10
- Net Profit Attributable to Parent(W RMB): 2179.43
- Net Profit Growth Rate(%): 658.50
- Weighted Return on Equity(%): 2.9700
- Operating Cash Flow Per Share(RMB): -0.1400
- Undistributed Profit Per Share(RMB): 0.2386
- Capital Reserve Per Share(RMB): 0.2436
2. Main Business
The main business covers:
- Research, production, and sales of Chinese patent medicines
3. Company Basic Information
- Company Name: Guangdong Jiaying Pharmaceutical Co., Ltd.
- Listing Date: 2007-12-18
- Industry: Pharmaceutical Manufacturing
- Address: Zone B, Dongsheng Industrial Park, Meizhou City, Guangdong Province
- Website: gdjyzy.com.cn
- Company Profile：The company was established as a joint-stock company through the overall transformation of Meizhou Jiaying Pharmaceutical Co., Ltd., approved by the Guangdong Provincial People's Government Office's reply letter Yue Ban Han [2005] No. 235. The promoters were Huang Xiaobiao, Chen Yonghong, Huang Zhiyong, Huang Junmin, and Huang Libing. Based on the audited total net assets of 49.20 million yuan as of January 31, 2005, the company converted the capital into 49.20 million shares at a 1:1 ratio. The change was registered with the Guangdong Provincial Administration for Industry and Commerce on June 1, 2005, with registration number 4400001010598 and registered capital of 49.20 million yuan.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Orient Securities Co., Ltd. | Securities Company | 5214.80 | 10.28 |
| 2 | Yangtianhe Pharmacy Co., Ltd. | General Legal Person | 3552.57 | 7.00 |
| 3 | Guangdong Jiaying Venture Capital Fund Management Co., Ltd. | General Legal Person | 1600.31 | 3.15 |
| 4 | Guangdong Runxing Private Securities Investment Fund Management Co., Ltd. - Runxing Xinze No.1 Private Securities Investment Fund | Private Securities Investment Fund | 460.00 | 0.91 |
5. Concept Sectors
- Margin Trading & Securities Lending
- Heavily Held by Securities Firms
- Employee Stock Ownership
- Newly Entered by Private Funds
- Micro & Small Cap Stocks
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information